Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer

Sandra M Swain; José Baselga; Kim Sung-Bae; S Kim; Jungsil Ro; Vladimir Semiglazov; Mario Campone; Eva Ciruelos; Jean-Marc Ferrero; Andreas Schneeweiss; Sarah Heeson; Emma Clark; Ross Graham; Mark C Benyunes; Cortés Javies; Pirkko-Liisa Kellokumpu-Lehtinen

doi:10.1056/nejmoa1413513

Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer

Sandra M Swain, José Baselga, Kim Sung-Bae, S Kim, Jungsil Ro, Vladimir Semiglazov, Mario Campone, Eva Ciruelos, Jean-Marc Ferrero, Andreas Schneeweiss, Sarah Heeson, Emma Clark, Ross Graham, Mark C Benyunes, Cortés Javies, Pirkko-Liisa Kellokumpu-Lehtinen

Department of Oncology

Research output: Contribution to journal › Article › Scientific › peer-review

1054 Citations (Scopus)

Original language	English
Pages (from-to)	724-734
Journal	NEW ENGLAND JOURNAL OF MEDICINE
Volume	372
Issue number	8
DOIs	https://doi.org/10.1056/nejmoa1413513
Publication status	Published - 2015
Publication type	A1 Journal article-refereed

Publication forum classification

Publication forum level 3

Access to Document

10.1056/nejmoa1413513

http://urn.fi/urn:nbn:fi:uta-201602161221

Cite this

Swain, S. M., Baselga, J., Sung-Bae, K., Kim, S., Ro, J., Semiglazov, V., Campone, M., Ciruelos, E., Ferrero, J-M., Schneeweiss, A., Heeson, S., Clark, E., Graham, R., Benyunes, M. C., Javies, C., & Kellokumpu-Lehtinen, P-L. (2015). Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. NEW ENGLAND JOURNAL OF MEDICINE, 372(8), 724-734. https://doi.org/10.1056/nejmoa1413513

Swain, Sandra M ; Baselga, José ; Sung-Bae, Kim ; Kim, S ; Ro, Jungsil ; Semiglazov, Vladimir ; Campone, Mario ; Ciruelos, Eva ; Ferrero, Jean-Marc ; Schneeweiss, Andreas ; Heeson, Sarah ; Clark, Emma ; Graham, Ross ; Benyunes, Mark C ; Javies, Cortés ; Kellokumpu-Lehtinen, Pirkko-Liisa. / Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. In: NEW ENGLAND JOURNAL OF MEDICINE. 2015 ; Vol. 372, No. 8. pp. 724-734.

@article{86c31f6f2d514f01ab921eb4cc1c4ed0,

title = "Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer",

author = "Swain, {Sandra M} and Jos{\'e} Baselga and Kim Sung-Bae and S Kim and Jungsil Ro and Vladimir Semiglazov and Mario Campone and Eva Ciruelos and Jean-Marc Ferrero and Andreas Schneeweiss and Sarah Heeson and Emma Clark and Ross Graham and Benyunes, {Mark C} and Cort{\'e}s Javies and Pirkko-Liisa Kellokumpu-Lehtinen",

year = "2015",

doi = "10.1056/nejmoa1413513",

language = "English",

volume = "372",

pages = "724--734",

journal = "NEW ENGLAND JOURNAL OF MEDICINE",

issn = "0028-4793",

number = "8",

}

Swain, SM, Baselga, J, Sung-Bae, K, Kim, S, Ro, J, Semiglazov, V, Campone, M, Ciruelos, E, Ferrero, J-M, Schneeweiss, A, Heeson, S, Clark, E, Graham, R, Benyunes, MC, Javies, C & Kellokumpu-Lehtinen, P-L 2015, 'Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer', NEW ENGLAND JOURNAL OF MEDICINE, vol. 372, no. 8, pp. 724-734. https://doi.org/10.1056/nejmoa1413513

Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. / Swain, Sandra M; Baselga, José; Sung-Bae, Kim; Kim, S; Ro, Jungsil; Semiglazov, Vladimir; Campone, Mario; Ciruelos, Eva; Ferrero, Jean-Marc; Schneeweiss, Andreas; Heeson, Sarah; Clark, Emma; Graham, Ross; Benyunes, Mark C; Javies, Cortés; Kellokumpu-Lehtinen, Pirkko-Liisa.

In: NEW ENGLAND JOURNAL OF MEDICINE, Vol. 372, No. 8, 2015, p. 724-734.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer

AU - Swain, Sandra M

AU - Baselga, José

AU - Sung-Bae, Kim

AU - Kim, S

AU - Ro, Jungsil

AU - Semiglazov, Vladimir

AU - Campone, Mario

AU - Ciruelos, Eva

AU - Ferrero, Jean-Marc

AU - Schneeweiss, Andreas

AU - Heeson, Sarah

AU - Clark, Emma

AU - Graham, Ross

AU - Benyunes, Mark C

AU - Javies, Cortés

AU - Kellokumpu-Lehtinen, Pirkko-Liisa

PY - 2015

Y1 - 2015

U2 - 10.1056/nejmoa1413513

DO - 10.1056/nejmoa1413513

M3 - Article

VL - 372

SP - 724

EP - 734

JO - NEW ENGLAND JOURNAL OF MEDICINE

JF - NEW ENGLAND JOURNAL OF MEDICINE

SN - 0028-4793

IS - 8

ER -